Main menu

Targeted nanopore sequencing ushers in the era of routine long-read sequencing in translational research laboratories


Abstract

Nanopore sequencing offers attractive prospects for clinical laboratories with translational research activities: methylation analysis, variant phasing, gene fusion detection, and single nucleotide and structural variant detection. Using a collection of tumour and germline samples, we show how targeted sequencing with adaptive sampling enables the in-depth characterisation of relevant genomic regions on a single MinION Flow Cell per sample. This illustrates how nanopore sequencing can be made accessible for small-scale projects, and scalable to the systematic characterisation of samples in a translational research setting.

To learn more about other applications of nanopore sequencing in cancer research, click here.

Authors: Abderaouf Hamza

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag